Produced by Araxis Merge on 3/30/2018 9:10:41 AM Central Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
# | Location | File | Last Modified |
---|---|---|---|
1 | CAS_RxSU2_Build-2_Sprint-1.zip\CAS_RxSU2_Build-2_Sprint-1_Documentation\CAS_RxSU2_Build_2_Sprint-1_Test_Cases | CAS_Test_Case_RxSU2_TC_008.docx | Fri Mar 9 14:48:21 2018 UTC |
2 | CAS_RxSU2_Build-2_Sprint-1.zip\CAS_RxSU2_Build-2_Sprint-1_Documentation\CAS_RxSU2_Build_2_Sprint-1_Test_Cases | CAS_Test_Case_RxSU2_TC_008.docx | Thu Mar 29 21:37:17 2018 UTC |
Description | Between Files 1 and 2 |
|
---|---|---|
Text Blocks | Lines | |
Unchanged | 1 | 492 |
Changed | 0 | 0 |
Inserted | 0 | 0 |
Removed | 0 | 0 |
Whitespace | |
---|---|
Character case | Differences in character case are significant |
Line endings | Differences in line endings (CR and LF characters) are ignored |
CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
1 | Option | |
2 | ||
3 | Department of Vetera ns Affairs | |
4 | ||
5 | Clinical A ncillary S ervices (C AS) | |
6 | ||
7 | ||
8 | Sprint-1 | |
9 | Test Case CAS_RxSU2_ TC_008 | |
10 | CLIN# 2004 AE | |
11 | February 2 018 | |
12 | Version 1. 0 | |
13 | Revision H istory | |
14 | Date | |
15 | Version | |
16 | Descriptio n | |
17 | Author | |
18 | 02/15/2018 | |
19 | 1.0 | |
20 | Print Haza rdous Medi cations In formation on Inpati ent Medica tion Dispe nsing Repo rts | |
21 | Samuel Gut ema | |
22 | ||
23 | Table of C ontents | |
24 | 1Product D escription 1 | |
25 | 1.1Purpose 1 | |
26 | 1.2Scope1 | |
27 | 2Test Case 1 | |
28 | Appendix A .Acronyms & Abbrevia tions5 | |
29 | ||
30 | ||
31 | Product De scription | |
32 | OneVA Phar macy Clini cal Ancill ary Servic es (CAS) p roject | |
33 | Purpose | |
34 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate as a clinicia n or pharm acy person nel handli ng hazardo us medicat ions, I wa nt informa tion alert ing me tha t a medica tion is ha zardous to handle, s o that I a m able to take appro priate pre cautions. | |
35 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
36 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
37 | Scope | |
38 | As a clini cian or ph armacy per sonnel han dling haza rdous medi cations, I want info rmation al erting me that a med ication is hazardous to handle , so that I am able to take ap propriate precaution s. | |
39 | 2.0 Test C ase | |
40 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakehold ers can al so provide inputs ab out the cu rrent set of test ca ses as wel l as sugge st some mo re missing test case s. | |
41 | This test case will: | |
42 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
43 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
44 | ||
45 | Field | |
46 | Descriptio n | |
47 | Test Case ID: | |
48 | CAS_RxSU2_ TC_008 | |
49 | RTC ID: | |
50 | ||
51 | RM ID: | |
52 | ||
53 | QM ID: | |
54 | ||
55 | Tester: | |
56 | Samuel Gut ema | |
57 | Environmen t: | |
58 | CHYSHR, DA YTSHR | |
59 | Build : | |
60 | ||
61 | Use Case N ame: | |
62 | PRE-Requir ements res earch and prototype coding for Hazardous Medicatio n Handling | |
63 | Scenario: | |
64 | As a clini cian or ph armacy per sonnel han dling haza rdous medi cations, I want info rmation al erting me that a med ication is hazardous to handle , so that I am able to take ap propriate precaution s. | |
65 | Actors: | |
66 | Pharmacist | |
67 | Pre-Condit ion: | |
68 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
69 | ||
70 | ||
71 | Post-Condi tion | |
72 | If the haz ardous to handle ind icator is set to yes , I want t o be able to identif y the medi cation as hazardous to handle prior to d ispensing. | |
73 | I want an visual ind icator pri nted on th e followin g: | |
74 | Pharmacy P ick List | |
75 | Pre-Cart E xchange Re port | |
76 | Medication Labels (I V & Unit D ose) | |
77 | Manufactur ing List | |
78 | If the haz ardous to dispose in dicator is set to ye s, I want to be able to identi fy the med ication as hazardous to dispos e prior to dispensin g. | |
79 | I want an visual ind icator pri nted on th e followin g: | |
80 | Pharmacy P ick List | |
81 | Pre-Cart E xchange Re port | |
82 | Medication Labels (I V & Unit D ose) | |
83 | Manufactur ing List | |
84 | ||
85 | ||
86 | ||
87 | ||
88 | ||
89 | Steps | |
90 | Actions an d Expected Results | |
91 | Pass | |
92 | Fail | |
93 | ||
94 | Actions | |
95 | ||
96 | ||
97 | ||
98 | Log into y our local vista inst ance. | |
99 | ||
100 | ||
101 | ||
102 | Expected R esults | |
103 | ||
104 | ||
105 | ||
106 | User will be taken t o the acce ss/verify code promp ts. | |
107 | ||
108 | ||
109 | ||
110 | Actions | |
111 | ||
112 | ||
113 | ||
114 | ||
115 | Enter your access/ve rify code( s). | |
116 | ||
117 | ||
118 | ||
119 | Expected R esults | |
120 | ||
121 | ||
122 | ||
123 | User is ta ken to the default m enu prompt . | |
124 | ||
125 | ||
126 | ||
127 | Actions | |
128 | ||
129 | ||
130 | ||
131 | ||
132 | ||
133 | ||
134 | Navigate t o the menu option ‘P harmacist Menu’ | |
135 | ||
136 | ||
137 | ||
138 | Expected R esults | |
139 | ||
140 | ||
141 | ||
142 | User is pr ompted for ‘Division ’. | |
143 | ||
144 | ||
145 | ||
146 | Actions | |
147 | ||
148 | ||
149 | ||
150 | When promp ted for ‘D ivision’, select the division associated with your pharmacy system. | |
151 | ||
152 | ||
153 | ||
154 | Expected R esults | |
155 | ||
156 | ||
157 | ||
158 | User is ta ken to the next prom pt. | |
159 | ||
160 | ||
161 | ||
162 | Actions | |
163 | ||
164 | ||
165 | ||
166 | When promp ted to ‘Se lect Label printer’, press <re turn> | |
167 | ||
168 | ||
169 | ||
170 | Expected R esults | |
171 | ||
172 | ||
173 | ||
174 | User is ta ken to the next prom pt. | |
175 | ||
176 | ||
177 | ||
178 | Actions | |
179 | ||
180 | ||
181 | ||
182 | When promp ted ‘Right Margin’, press <ret urn> | |
183 | ||
184 | ||
185 | ||
186 | Expected R esults | |
187 | ||
188 | ||
189 | ||
190 | User is ta ken to the next prom pt | |
191 | ||
192 | ||
193 | ||
194 | Actions | |
195 | ||
196 | ||
197 | ||
198 | ||
199 | ||
200 | If prompte d ‘OK to a ssume labe l alignmen t is corre ct’, press <return> | |
201 | ||
202 | ||
203 | ||
204 | Expected R esults | |
205 | ||
206 | ||
207 | ||
208 | User is ta ken to the next prom pt. | |
209 | ||
210 | ||
211 | ||
212 | Actions | |
213 | ||
214 | ||
215 | ||
216 | When promp ted ‘Bingo Board Dis play:”, pr ess <retur n> | |
217 | ||
218 | ||
219 | ||
220 | Expected R esults | |
221 | ||
222 | ||
223 | ||
224 | User is ta ken to the next menu list for outpatient pharmacy. | |
225 | ||
226 | ||
227 | ||
228 | ||
229 | ||
230 | ||
231 | ||
232 | Acronyms & Abbreviat ions | |
233 | Acronym | |
234 | Definition | |
235 | CAS | |
236 | Clinical A ncillary S ervices | |
237 | CHYSHR | |
238 | Test Envir onment fo r Host sit e | |
239 | CPRS | |
240 | Computeriz ed Patient Record Sy stem | |
241 | DAYTSHR | |
242 | Test Envir onment fo r the disp ensing sit e (remote) | |
243 | VHA | |
244 | Veteran’s Health Adm inistratio n | |
245 | VistA | |
246 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.